Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Evans

Showing results (111-120 of 208) with videos related to

Pageof 21
Sort By:
Genes & Cancer|March 29, 2011
Andrographolide, an herbal medicine, inhibits interleukin-6 expression and suppresses prostate cancer cell growthJae Yeon Chun, Ramakumar Tummala, Nagalakshmi Nadiminty, et al.
Cancer Research|April 15, 2010
Aberrant activation of the androgen receptor by NF-kappaB2/p52 in prostate cancer cellsNagalakshmi Nadiminty, Wei Lou, Meng Sun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2009
Interleukin-6 regulates androgen synthesis in prostate cancer cellsJae Yeon Chun, Nagalakshmi Nadiminty, Smitha Dutt, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 23, 2003
Application of a yeast assay to detect functional p53 mutations in archival prostate cancer tissueXu-Bao Shi, Stephen M Di Mauro, Ralph Highshaw, et al.
Anti-Cancer Drugs|April 28, 2009
A phase II trial of the Src-kinase inhibitor AZD0530 in patients with advanced castration-resistant prostate cancer: a California Cancer Consortium studyPrimo N Lara, Jeff Longmate, Christopher P Evans, et al.
JAMA Oncology|August 28, 2020
Assessment of Postprostatectomy Radiotherapy as Adjuvant or Salvage Therapy in Patients With Prostate Cancer: A Systematic ReviewSean Sachdev, Peter Carroll, Howard Sandler, et al.
Urology Practice|August 18, 2023
Perioperative Outcomes following Neoadjuvant Chemotherapy and Radical Cystectomy-Is There Room for Improvement?Neil Pugashetti, Thenappan Chandrasekar, Robert Lurvey, et al.
Genes & Cancer|July 23, 2011
Andrographolide targets androgen receptor pathway in castration-resistant prostate cancerChengfei Liu, Nagalakshmi Nadiminty, Ramakumar Tummala, et al.
Molecular Cancer Therapeutics|July 26, 2019
GnRH Antagonists Have Direct Inhibitory Effects On Castration-Resistant Prostate Cancer Via Intracrine Androgen and AR-V7 ExpressionVito Cucchiara, Joy C Yang, Chengfei Liu, et al.
JAMA Network Open|June 15, 2021
Comparison of Joint and Landmark Modeling for Predicting Cancer Progression in Men With Castration-Resistant Prostate Cancer: A Secondary Post Hoc Analysis of the PREVAIL Randomized Clinical TrialAntonio Finelli, Tomasz M Beer, Simon Chowdhury, et al.
Pageof 21

Showing results (111-120 of 208) with videos related to

Sort By:
Pageof 21
Genes & Cancer|March 29, 2011
Andrographolide, an herbal medicine, inhibits interleukin-6 expression and suppresses prostate cancer cell growthJae Yeon Chun, Ramakumar Tummala, Nagalakshmi Nadiminty, et al.
Cancer Research|April 15, 2010
Aberrant activation of the androgen receptor by NF-kappaB2/p52 in prostate cancer cellsNagalakshmi Nadiminty, Wei Lou, Meng Sun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2009
Interleukin-6 regulates androgen synthesis in prostate cancer cellsJae Yeon Chun, Nagalakshmi Nadiminty, Smitha Dutt, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 23, 2003
Application of a yeast assay to detect functional p53 mutations in archival prostate cancer tissueXu-Bao Shi, Stephen M Di Mauro, Ralph Highshaw, et al.
Anti-Cancer Drugs|April 28, 2009
A phase II trial of the Src-kinase inhibitor AZD0530 in patients with advanced castration-resistant prostate cancer: a California Cancer Consortium studyPrimo N Lara, Jeff Longmate, Christopher P Evans, et al.
JAMA Oncology|August 28, 2020
Assessment of Postprostatectomy Radiotherapy as Adjuvant or Salvage Therapy in Patients With Prostate Cancer: A Systematic ReviewSean Sachdev, Peter Carroll, Howard Sandler, et al.
Urology Practice|August 18, 2023
Perioperative Outcomes following Neoadjuvant Chemotherapy and Radical Cystectomy-Is There Room for Improvement?Neil Pugashetti, Thenappan Chandrasekar, Robert Lurvey, et al.
Genes & Cancer|July 23, 2011
Andrographolide targets androgen receptor pathway in castration-resistant prostate cancerChengfei Liu, Nagalakshmi Nadiminty, Ramakumar Tummala, et al.
Molecular Cancer Therapeutics|July 26, 2019
GnRH Antagonists Have Direct Inhibitory Effects On Castration-Resistant Prostate Cancer Via Intracrine Androgen and AR-V7 ExpressionVito Cucchiara, Joy C Yang, Chengfei Liu, et al.
JAMA Network Open|June 15, 2021
Comparison of Joint and Landmark Modeling for Predicting Cancer Progression in Men With Castration-Resistant Prostate Cancer: A Secondary Post Hoc Analysis of the PREVAIL Randomized Clinical TrialAntonio Finelli, Tomasz M Beer, Simon Chowdhury, et al.
Pageof 21